Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization

Vaccine

Volumn 29, Issue 10, 2011, Pages 1981-1990

  Schabussova, Irma ^a   Hufnagl, Karin ^a   Wild, Carmen ^a   Nutten, Sophie ^b   Zuercher, Adrian W ^b   Mercenier, Annick ^b   Wiedermann, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Allergy; Mucosal interventions; Probiotics

Indexed keywords

POLLEN ANTIGEN; PROBIOTIC AGENT;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM LONGUM; BIRCH; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GRASS POLLEN; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; LACTOBACILLUS PARACASEI; MOUSE; NONHUMAN; POLLEN ALLERGY; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION;

ANIMALS; BETULA; BIFIDOBACTERIUM; FEMALE; IMMUNOLOGIC FACTORS; LACTOBACILLUS; MICE; MICE, INBRED BALB C; POACEAE; POLLEN; PROBIOTICS; RHINITIS, ALLERGIC, SEASONAL;

EID: 79951723669     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.101     Document Type: Article

References (65)

1. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118(July (2)):229-241.
2. Ruemmele F.M., Bier D., Marteau P., Rechkemmer G., Bourdet-Sicard R., Walker W.A., et al. Clinical evidence for immunomodulatory effects of probiotic bacteria. J Pediatr Gastroenterol Nutr 2009, 48(February (2)):126-141.
3. Alm B., Erdes L., Mollborg P., Pettersson R., Norvenius S.G., Aberg N., et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 2008, 1214(April):697-702.
4. Bjorksten B., Naaber P., Sepp E., Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999, 293(March):342-346.
5. Kalliomaki M., Kirjavainen P., Eerola E., Kero P., Salminen S., Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001, 1071(January):129-134.
6. Marra F., Marra C.A., Richardson K., Lynd L.D., Kozyrskyj A., Patrick D.M., et al. Antibiotic use in children is associated with increased risk of asthma. Pediatrics 2009, 1233(March):1003-1010.
7. Sjogren Y.M., Jenmalm M.C., Bottcher M.F., Bjorksten B., Sverremark-Ekstrom E. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy 2009, 39(February (4)):518-526.
8. Jones S.E., Versalovic J. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol 2009, 9:35.
9. Kuitunen M., Kukkonen K., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009, 1232(February):335-341.
10. Lee do K., Jang S., Kim M.J., Kim J.H., Chung M.J., Kim K.J., et al. Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines. BMC Cancer 2008, 8:310.
11. Olivares M., Diaz-Ropero M.P., Gomez N., Lara-Villoslada F., Sierra S., Maldonado J.A., et al. The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int Microbiol 2006, 9(March (1)):47-52.
12. Kalliomaki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001, 357(April (9262)):1076-1079.
13. Kalliomaki M., Salminen S., Poussa T., Arvilommi H., Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361(May (9372)):1869-1871.
14. Kalliomaki M., Salminen S., Poussa T., Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007, 119(April (4)):1019-1021.
15. Blumer N., Sel S., Virna S., Patrascan C.C., Zimmermann S., Herz U., et al. Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. Clin Exp Allergy 2007, 37(March (3)):348-357.
16. Feleszko W., Jaworska J., Rha R.D., Steinhausen S., Avagyan A., Jaudszus A., et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007, 37(April (4)):498-505.
17. Helin T., Haahtela S., Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002, 57(March (3)):243-246.
18. Wheeler J.G., Shema S.J., Bogle M.L., Shirrell M.A., Burks A.W., Pittler A., et al. Immune and clinical impact of Lactobacillus acidophilus on asthma. Ann Allergy Asthma Immunol 1997, 79(September (3)):229-233.
19. Rose M.A., Stieglitz F., Koksal A., Schubert R., Schulze J., Zielen S. Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk. Clin Exp Allergy 2010, 40(September (9)):1398-1405.
20. Lee J., Seto D., Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008, 121(January (1)). 116-21e11.
21. Viljanen M., Pohjavuori E., Haahtela T., Korpela R., Kuitunen M., Sarnesto A., et al. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol 2005, 115(June (6)):1254-1259.
22. Marschan E., Kuitunen M., Kukkonen K., Poussa T., Sarnesto A., Haahtela T., et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008, 38(April (4)):611-618.
23. Mohamadzadeh M., Klaenhammer T.R. Specific Lactobacillus species differentially activate Toll-like receptors and downstream signals in dendritic cells. Expert Rev Vaccines 2008, 7(October (8)):1155-1164.
24. Mohamadzadeh M., Olson S., Kalina W.V., Ruthel G., Demmin G.L., Warfield K.L., et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA 2005, 102(February (8)):2880-2885.
25. Daniel C., Repa A., Wild C., Pollak A., Pot B., Breiteneder H., et al. Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 2006, 61(July (7)):812-819.
26. Wild J.S., Sigounas A., Sur N., Siddiqui M.S., Alam R., Kurimoto M., et al. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. J Immunol 2000, 164(March (5)):2701-2710.
27. Mikhak Z., Farsidjani A., Luster A.D. Endotoxin augmented antigen-induced Th1 cell trafficking amplifies airway neutrophilic inflammation. J Immunol 2009, 182(June (12)):7946-7956.
28. Schulze-Koops H., Kalden J.R. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001, 15(December (5)):677-691.
29. Skapenko A., Lipsky P.E., Schulze-Koops H. T cell activation as starter and motor of rheumatic inflammation. Curr Top Microbiol Immunol 2006, 305:195-211.
30. Trembleau S., Penna G., Bosi E., Mortara A., Gately M.K., Adorini L. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995, 181(February (2)):817-821.
31. Verhagen J., Akdis M., Traidl-Hoffmann C., Schmid-Grendelmeier P., Hijnen D., Knol E.F., et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006, 117(January (1)):176-183.
32. Yazdanbakhsh M., Kremsner P.G., van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002, 296(April (5567)):490-494.
33. Akdis M. T cell tolerance to inhaled allergens: mechanisms and therapeutic approaches. Expert Opin Biol Ther 2008, 8(June (6)):769-777.
34. Jutel M., Akdis M., Budak F., Aebischer-Casaulta C., Wrzyszcz M., Blaser K., et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003, 33(May (5)):1205-1214.
35. Wiedermann U., Jahn-Schmid B., Bohle B., Repa A., Renz H., Kraft D., et al. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy. J Allergy Clin Immunol 1999, 103(June (6)):1202-1210.
36. Hufnagl K., Winkler B., Focke M., Valenta R., Scheiner O., Renz H., et al. Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice. J Allergy Clin Immunol 2005, 116(August (2)):370-376.
37. Repa A., Wild C., Hufnagl K., Winkler B., Bohle B., Pollak A., et al. Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy. Clin Exp Immunol 2004, 137(July (1)):12-18.
38. Hufnagl K., Wagner B., Winkler B., Baier K., Hochreiter R., Thalhamer J., et al. Induction of mucosal tolerance with recombinant Hev b 1 and recombinant Hev b 3 for prevention of latex allergy in BALB/c mice. Clin Exp Immunol 2003, 133(August (2)):170-176.
39. Aaby P., Shaheen S.O., Heyes C.B., Goudiaby A., Hall A.J., Shiell A.W., et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000, 30(May (5)):644-650.
40. Wagner A., Forster-Waldl E., Garner-Spitzer E., Schabussova I., Kundi M., Pollak A., et al. Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice. Int J Parasitol 2009, 39(March (4)):465-472.
41. Pessi T., Sutas Y., Hurme M., Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000, 30(December (12)):1804-1808.
42. Smits H.H., Engering A., van der Kleij D., de Jong E.C., Schipper K., van Capel T.M., et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005, 115(June (6)):1260-1267.
43. Bickert T., Trujillo-Vargas C.M., Duechs M., Wohlleben G., Polte T., Hansen G., et al. Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways. Int Arch Allergy Immunol 2009, 149(February (3)):219-230.
44. Nonaka Y., Izumo T., Izumi F., Maekawa T., Shibata H., Nakano A., et al. Antiallergic effects of Lactobacillus pentosus strain S-PT84 mediated by modulation of Th1/Th2 immunobalance and induction of IL-10 production. Int Arch Allergy Immunol 2008, 145(3):249-257.
45. Torii A., Torii S., Fujiwara S., Tanaka H., Inagaki N., Nagai H. Lactobacillus Acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol Int 2007, 56(September (3)):293-301.
46. Segawa S., Nakakita Y., Takata Y., Wakita Y., Kaneko T., Kaneda H., et al. Effect of oral administration of heat-killed Lactobacillus brevis SBC8803 on total and ovalbumin-specific immunoglobulin E production through the improvement of Th1/Th2 balance. Int J Food Microbiol 2008, 121(January (1)):1-10.
47. Fasce L., Tosca M.A., Olcese R., Milanese M., Erba D., Ciprandi G. The natural history of allergy: the development of new sensitizations in asthmatic children. Immunol Lett 2004, 93(April (1)):45-50.
48. Antonicelli L., Micucci C., Voltolini S., Feliziani V., Senna G.E., Di Blasi P., et al. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin Exp Allergy 2007, 37(June (6)):954-960.
49. Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108(November (5 Suppl.)):S147-334.
50. Eriksson N.E., Holmen A. Skin prick tests with standardized extracts of inhalant allergens in 7099 adult patients with asthma or rhinitis: cross-sensitizations and relationships to age, sex, month of birth and year of testing. J Investig Allergol Clin Immunol 1996, 6(January-February (1)):36-46.
51. Silvestri M., Rossi G.A., Cozzani S., Pulvirenti G., Fasce L. Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children. Ann Allergy Asthma Immunol 1999, 83(October (4)):335-340.
52. Couch R.B. Nasal vaccination. Escherichia coli enterotoxin, and Bell's palsy. The New England journal of medicine 2004, 350(February (9)):860-861.
53. Wiedermann U., Jahn-Schmid B., Repa A., Kraft D., Ebner C. Modulation of an allergic immune response via the mucosal route in a murine model of inhalative type-I allergy. Int Arch Allergy Immunol 1999, 118(February-April (2-4)):129-132.
54. Ohno H., Tsunemine S., Isa Y., Shimakawa M., Yamamura H. Oral administration of Bifidobacterium bifidum G9-1 suppresses total and antigen specific immunoglobulin E production in mice. Biol Pharm Bull 2005, 28(August (8)):1462-1466.
55. Nair M.G., Du Y., Perrigoue J.G., Zaph C., Taylor J.J., Goldschmidt M., et al. Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung. J Exp Med 2009, 206(April (4)):937-952.
56. Smits H.H., Gloudemans A.K., van Nimwegen M., Willart M.A., Soullie T., Muskens F., et al. Cholera toxin B suppresses allergic inflammation through induction of secretory IgA. Mucosal Immunol 2009, 2(July (4)):331-339.
57. Taylor B., Fergusson D.M., Mahoney G.N., Hartley W.A., Abbott J. Specific IgA and IgE in childhood asthma, eczema and food allergy. Clin Allergy 1982, 12(September (5)):499-505.
58. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001, 2(August (8)):725-731.
59. Winkler B., Bolwig C., Seppala U., Spangfort M.D., Ebner C., Wiedermann U. Allergen-specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy. Immunology 2003, 110(November (3)):376-385.
60. Sur S., Wild J.S., Choudhury B.K., Sur N., Alam R., Klinman D.M. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 1999, 162(May (10)):6284-6293.
61. Foligne B., Nutten S., Grangette C., Dennin V., Goudercourt D., Poiret S., et al. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 2007, 13(January (2)):236-243.
62. Velasco G., Campo M., Manrique O.J., Bellou A., He H., Arestides R.S., et al. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol 2005, 32(March (3)):218-224.
63. Bortolatto J., Borducchi E., Rodriguez D., Keller A.C., Faquim-Mauro E., Bortoluci K.R., et al. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis. Clin Exp Allergy 2008, 38(October (10)):1668-1679.
64. Lauener R.P., Birchler T., Adamski J., Braun-Fahrlander C., Bufe A., Herz U., et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002, 360(August (9331)):465-466.
65. Xiao J.Z., Kondo S., Yanagisawa N., Takahashi N., Odamaki T., Iwabuchi N., et al. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin Exp Allergy 2006, 36(November (11)):1425-1435.